Clinical Trials Logo

Filter by:
NCT ID: NCT03234166 Completed - Clinical trials for Acute Necrotizing Pancreatitis

Acute Necrotizing Pancreatitis and Infected Pancreatic Necrosis

PANIC
Start date: March 1, 2018
Phase:
Study type: Observational

Acute necrotizing pancreatitis is a frequent and potentially lethal disease, especially in case of infected pancreatic necrosis (IPN). IPN usually occurs after the first week of evolution. The step up approach is now widely recommended for the management of IPN. In fact, in case of suspicion of IPN, a drainage percutaneous or transgastric is recommended at first, supported by probabilist antibiotherapy. 1/3 of patients won't require any other interventions. For 2/3 of patients, an additional necrosectomy is necessary. Necrosectomy was formally realized by open laparotomy. Since de last decade, mini-invasive technics have emerged: transgastric necrosectomy, video-assist retroperitoneal debridement. laparoscopy and permitted a decreased of morbidity and mortality. Recently, Hollemans et al. developed a nomogram based on 4 variables (sex, multi-organ failure, % of necrosis and collections heterogeneity) which are negative predictors for success of catheter drainage in IPN with an receiver operating characteristic (ROC) curve at 0.76. The aim of this study is to validate on a large retrospective cohort Hollemans nomogram in predicting catheter drainage success. Secondary aims are to evaluate possible others predictors for success of catheter drainage in IPN and to evaluate the impact of antibiotherapy on microbiological results and on the need for an additional necrosectomy regarding its type and duration, as well as the emergence of multiresistance organism.

NCT ID: NCT03234127 Completed - Clinical trials for Homozygous Familial Hypercholesterolemia

Study of cardiovAscular Contrasted Phenotypes in Patients With FamIliaI hypercholesteRolemia

SAFIR
Start date: December 6, 2017
Phase: N/A
Study type: Interventional

The main objective of SAFIR is to identify the atherosclerotic genetic factors in these patients, which will identify new therapeutic targets for the treatment of CV and Familial Hypercholesterolemia diseases. In addition, SAFIR will allow the identification of new CV protection biomarkers, which will be useful tools for the development of a personalized medicine for the management of dyslipidemias.

NCT ID: NCT03233984 Completed - Pregnancy Clinical Trials

Effect of an Environmental Health Education Program on Pregnant Women in Order to Reduce Endocrine Disruptor Exposition

Start date: April 19, 2017
Phase: N/A
Study type: Interventional

Endocrine disruptors are known as a cancer cause. On pregnant women, it can induce major foetal pathology and impact growth. Among those molecules, bisphenol-A (BPA) is a plasticizer that can be found on cans and water. Through a prevention program, the investigators tried to warned pregnant women on endocrine disruptors exposition risks. The goal here is to assess the effectiveness of this program on their fresh products consumption.

NCT ID: NCT03233282 Completed - Healthy Clinical Trials

EEG Monitoring for PERFormance Anticipation

MEEGAPERF
Start date: May 30, 2013
Phase: N/A
Study type: Interventional

Identify, characterize and then validate electrophysiological markers linking electrophysiological cerebral activity and performance in cognitive and physical fatigability in humans. To do this, noninvasive explorations of electroencephalography (EEG) and magnetoencephalography (MEG) will be carried out under two conditions of different experiments, the first one that induces a cognitive fatigability and the second one that induces physical fatigability.

NCT ID: NCT03232944 Completed - Heart Failure Clinical Trials

Personalized CRT - MPP Post Approval Study

Start date: July 5, 2017
Phase:
Study type: Observational [Patient Registry]

The purpose of this Post-Approval Study (PAS) is to evaluate the effectiveness of MPP to improve CRT response in the non-responder patient population when used in "real-world" clinical practice, following commercial release. This evaluation is based on the Clinical Composite Score which summarizes the proportions and frequencies of CRT non-responder patients who are "improved", "unchanged" or "worsened" after receiving MPP therapy. Patients will be followed for the duration of the PAS. This study is required by FDA as a condition of approval of the MPP feature and is integrated within the Product Surveillance Registry (PSR).

NCT ID: NCT03232853 Completed - Clinical trials for Medical Errors : Drugs Errors During Anesthesia

E-learning to Prevent Drug Errors in Anesthesia

ELPdrug
Start date: July 31, 2017
Phase:
Study type: Observational

The purpose of this observational study is to assess the efficiency of an e-learning in order to put into practice some preventive measures to avoid medication errors during anesthesia.

NCT ID: NCT03232840 Completed - Clinical trials for Medical Errors : Wrong Site Surgery in Regional Anesthesia

E-learning to Prevent Wrong Site Surgery in Anesthesia

ELPSite
Start date: July 31, 2017
Phase:
Study type: Observational

The purpose of this observational study is to assess the efficiency of an e-learning in order to put into practice some preventive measures to avoid wrong site surgery during anesthesia.

NCT ID: NCT03232697 Completed - Cognitive Symptom Clinical Trials

French Language Validation of the 5-minutes Montreal Cognitive Assessment (MoCA)

MoCATEL
Start date: July 12, 2017
Phase: N/A
Study type: Interventional

The aim of the study is to validate a french version of the 5 minutes version of the Montreal Cognitive Assessment as compared to the french full version of this test.

NCT ID: NCT03232645 Completed - Clinical trials for Paroxysmal Atrial Fibrillation

Electrical Coupling Information From The Rhythmia HDx System And DirectSense Technology In Subjects With Paroxysmal Atrial Fibrillation

LOCALIZE
Start date: January 8, 2018
Phase: N/A
Study type: Interventional

The objective of the study is to collect data on the use of the Rhythmia HDx mapping system running commercially available Software Version 2.0 or any future commercially available Software Version with DirectSense technology and the IntellaMap OrionTM mapping catheter in patients indicated for ablation treatment for de-novo Paroxysmal Atrial Fibrillation (PAF). The study will collect specific information to characterize the DirectSense technology in subjects undergoing catheter-based endocardial mapping and ablation for de-novo PAF using a commercial Rhythmia HDx mapping system. The clinical local impedance data will be used in order to generate usage guidance on the DirectSense local impedance feature in the management of de-novo PAF cases requiring Pulmonary Vein Isolation (PVI) and in order to further develop a future lesion indexing feature.

NCT ID: NCT03232606 Completed - Asthma Clinical Trials

Physical Activity of Asthmatic Children

Asthmeact
Start date: September 25, 2017
Phase:
Study type: Observational

Physical activity is mandatory to the optimal development and health of children. The presence of asthmatic manifestations may influence the comportment of children and its family toward exercise and practice of sports. There no scientific argument to advice a reduction of physical activity in asthmatic children, but previous studies showed that physical activity is reduced in asthmatic children. The aim of this observational study is to evaluate the existing factors leading to this reduction of physical activity in asthmatic children and their families.